Oncodea

Marianne Sarcich’s story is one that stays with you. In this powerful new piece on the Oncodea blog, she shares how her diagnosis in 2016 wasn’t the result of a perfect system but it was a chain of lucky breaks. Her story is not just moving it is a reminder of why we do what we do at Oncodea. Because early cancer detection shouldn’t be left to chance. https://lnkd.in/gJVHxU4X #EarlyDetection #BreastCancerAwareness #Oncodea #PatientVoices #CancerSurvivor #WomensHealth

We’re proud to launch the Oncodea blog with a brilliant first piece by Dr. Michael Mina, MD, PhD In it, he lays out a bold vision: early cancer detection should be fast, accessible, and integrated into everyday care — not a luxury, but a standard. It’s a public health imperative, and one we’re building toward at Oncodea. Take a moment to read his perspective here 👇 🔗 https://lnkd.in/gPsQCUvn #Oncodea #MichaelMina #EarlyDetection #CancerCare #PublicHealth #Diagnostics #HealthcareInnovation

New on the Oncodea blog: What happens when a breast cancer diagnosis isn’t the result of a perfectly functioning healthcare system but a string of improbable lucky breaks? In this powerful, deeply personal blog, survivor and advocate Marianne Sarcich shares how her Stage 1 diagnosis in 2016 was caught not because of protocols or routine screenings, but because of a chain of near-misses, self-advocacy, and intuition. https://lnkd.in/gAUBndfi #BreastCancerAwareness #EarlyDetection #WomensHealth #PatientVoices #CancerSurvivor #Oncodea #DiagnosticGaps

Last week, we shared a big thought: early cancer detection can change everything. The conversation is just getting started. If you missed it, here’s our latest post where Dr. Michael Mina dives into why public health and early detection are inseparable. Some quick facts: - Stage I breast cancer has a 5-year survival rate of over 99% - Treating advanced cancer can be nearly ten times more expensive than treating it early - A test that is accurate but inaccessible does not save lives https://lnkd.in/gy3DKXGD

New from Oncodea — A must-read from one of the most forward-thinking minds in diagnostics. We’re honored to kick off the Oncodea blog with a perspective from Dr. Michael Mina, MD, PhD, a visionary in diagnostics and public health. He explains why early cancer detection must be fast, accessible, and a routine part of medical care. 🧠 Insightful, bold, and beautifully written. Read it here: https://lnkd.in/gy3DKXGD #Oncodea #EarlyDetection #CancerCare #PublicHealth #MichaelMina #Diagnostics #HealthEquity #Innovation

Big news from Team Oncodea. We're thrilled to share that Oncodea’s latest abstract has just been published at American Association for Cancer Research 2025! In this study, we explore our AI-powered, nano-IR molecular fingerprinting platform for early breast cancer detection—a mission that drives everything we do. Detecting cancer early, accurately, and non-invasively isn’t just a scientific goal. It’s a critical step toward improving outcomes and reducing the burden of late-stage detection. This work reflects the incredible dedication of our team and partners, and we're proud to be contributing to the growing momentum in cancer care innovations. Curious to see what we’ve been working on? You can check out the abstract here: https://lnkd.in/eiiSFzay To everyone who’s been cheering us on: Thank you! The future of cancer screening is coming into focus, and we’re honored to be part of that change. #AACR2025 #Oncodea #EarlyDetection #BreastCancerAwareness #CancerResearch #LiquidBiopsy #AIinHealthcare #PrecisionMedicine

As we’re wrapping up 2024, we're thrilled to announce the publication of not one, but two abstracts in collaboration with the esteemed Dr. David Dingli at Mayo Clinic, presented at the 2024 American Society of Hematology ASH Annual Meeting! These abstracts highlight groundbreaking insights into diagnosing and distinguishing complex conditions: 🔬 https://lnkd.in/gEMjkDtk 🔬https://lnkd.in/gvav4rEq By harnessing cutting-edge science and working alongside exceptional collaborators like Dr. Dingli, we continue to push the boundaries of innovation in early detection and diagnosis. ✨ A big thank you to Dr. David Dingli for his incredible expertise and dedication. This collaboration exemplifies the power of partnership in tackling some of medicine’s most complex challenges. Feel free to explore the abstracts via the links above and share your thoughts. Let’s spark a conversation!

Join us as we explore the frontiers of cancer care, celebrate medical breakthroughs, and find new sparks of hope with Dr. David Dingli! Now on YouTube. https://lnkd.in/gX6wv8uV